Kiadis Pharma « Terug naar discussie overzicht

Molmed versus Kiadis Pharma en aanverwante biotech aandelen

722 Posts, Pagina: « 1 2 3 4 5 6 ... 32 33 34 35 36 37 | Laatste

Omlaag ↓

MG76 17 maart 2020 12:36

Overname bod op molmed van 0.518 euro

Japan's AGC launches bid on Italy's Molmed worth up to 240 mln euros
Contributor
3-4 minuten

Published

Mar 17, 2020 3:18AM EDT

Japan's AGC has launched a takeover bid on all the shares of Italian biotech company Molmed in a deal worth up to 240 million euros ($267 million), AGC said in a statement on Tuesday.

MILAN, March 17 (Reuters) - Japan's AGC 5201.T has launched a takeover bid on all the shares of Italian biotech company Molmed MLMD.MI in a deal worth up to 240 million euros ($267 million), AGC said in a statement on Tuesday.

AGC is offering 0.518 euros per Molmed share, the equivalent of a premium of 110.3%.

AGC said Fininvest, the holding company of the family of former Prime Minister Silvio Berlusconi, had agreed to tender its stake in Molmed.

Fininvest owns around 23% of Molmed shares.

The aim of the bid is to delist Molmed, AGC said.

[verwijderd] 18 maart 2020 19:21

Alles nu gericht op de medische zorg. Geld te over zo hoor ik meneer Rutte.

722 Posts, Pagina: « 1 2 3 4 5 6 ... 32 33 34 35 36 37 | Laatste

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 924,10 -1,03 -0,11% 07 feb


Germany40^	21.738,40	-0,75%
BEL 20	4.337,66	+0,00%
Europe50^	5.319,41	-0,11%
US30^	44.342,20	0,00%
Nasd100^	21.508,40	0,00%
US500^	6.029,92	0,00%
Japan225^	38.404,40	0,00%
Gold spot	2.860,78	0,00%
EUR/USD	1,0327	0,00%
WTI	70,95	0,00%